| Quantity: | |
|---|---|
Elagolix Sodium is a medication used in the treatment of certain gynecological conditions, specifically endometriosis and uterine fibroids. It is an orally active gonadotropin-releasing hormone (GnRH) receptor antagonist.
Gonadotropin-releasing hormone (GnRH) is a hormone produced in the hypothalamus of the brain that plays a key role in regulating the release of other hormones involved in the menstrual cycle, such as luteinizing hormone (LH) and follicle-stimulating hormone (FSH). By blocking the GnRH receptors, Elagolix suppresses the production and release of LH and FSH, which subsequently reduces the levels of estrogen and progesterone in the body.
In endometriosis, a condition where tissue similar to the lining of the uterus grows outside of the uterus, estrogen can contribute to the growth and proliferation of these abnormal tissues, leading to pain and inflammation. By lowering estrogen levels, Elagolix can help manage the symptoms of endometriosis, such as pelvic pain.
In the case of uterine fibroids, which are non-cancerous growths of the uterus, estrogen can also promote their growth. By reducing estrogen levels, Elagolix may help shrink the fibroids and alleviate symptoms like heavy menstrual bleeding and pelvic pressure.
1.GnRH Receptor Antagonist: Elagolix Sodium works by blocking the GnRH receptors in the pituitary gland. GnRH is a hormone that signals the release of other hormones, such as luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which are responsible for regulating the menstrual cycle and the production of estrogen and progesterone.
2.Reduction of Estrogen and Progesterone: By antagonizing the GnRH receptors, Elagolix suppresses the release of LH and FSH, leading to a decrease in the levels of estrogen and progesterone in the body. Both endometriosis and uterine fibroids are conditions that are influenced by estrogen, and reducing its levels can help manage the associated symptoms.
Endometriosis: In endometriosis, tissue similar to the lining of the uterus (endometrial tissue) grows outside of the uterus, often causing pain, inflammation, and scarring. Estrogen can promote the growth and proliferation of these abnormal tissues. By lowering estrogen levels, Elagolix helps to reduce the growth and inflammation of endometrial tissue, thereby alleviating symptoms like pelvic pain and discomfort.
Uterine Fibroids: Uterine fibroids are non-cancerous growths of the uterus that can cause heavy menstrual bleeding, pelvic pressure, and pain. Similar to endometriosis, fibroids can be influenced by estrogen. By decreasing estrogen levels, Elagolix may help to shrink the fibroids and improve symptoms associated with these growths.
5kg/bag/drum or 10kg/bag/drum or according to customer’s requirements.
Elagolix Sodium is a medication used in the treatment of certain gynecological conditions, specifically endometriosis and uterine fibroids. It is an orally active gonadotropin-releasing hormone (GnRH) receptor antagonist.
Gonadotropin-releasing hormone (GnRH) is a hormone produced in the hypothalamus of the brain that plays a key role in regulating the release of other hormones involved in the menstrual cycle, such as luteinizing hormone (LH) and follicle-stimulating hormone (FSH). By blocking the GnRH receptors, Elagolix suppresses the production and release of LH and FSH, which subsequently reduces the levels of estrogen and progesterone in the body.
In endometriosis, a condition where tissue similar to the lining of the uterus grows outside of the uterus, estrogen can contribute to the growth and proliferation of these abnormal tissues, leading to pain and inflammation. By lowering estrogen levels, Elagolix can help manage the symptoms of endometriosis, such as pelvic pain.
In the case of uterine fibroids, which are non-cancerous growths of the uterus, estrogen can also promote their growth. By reducing estrogen levels, Elagolix may help shrink the fibroids and alleviate symptoms like heavy menstrual bleeding and pelvic pressure.
1.GnRH Receptor Antagonist: Elagolix Sodium works by blocking the GnRH receptors in the pituitary gland. GnRH is a hormone that signals the release of other hormones, such as luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which are responsible for regulating the menstrual cycle and the production of estrogen and progesterone.
2.Reduction of Estrogen and Progesterone: By antagonizing the GnRH receptors, Elagolix suppresses the release of LH and FSH, leading to a decrease in the levels of estrogen and progesterone in the body. Both endometriosis and uterine fibroids are conditions that are influenced by estrogen, and reducing its levels can help manage the associated symptoms.
Endometriosis: In endometriosis, tissue similar to the lining of the uterus (endometrial tissue) grows outside of the uterus, often causing pain, inflammation, and scarring. Estrogen can promote the growth and proliferation of these abnormal tissues. By lowering estrogen levels, Elagolix helps to reduce the growth and inflammation of endometrial tissue, thereby alleviating symptoms like pelvic pain and discomfort.
Uterine Fibroids: Uterine fibroids are non-cancerous growths of the uterus that can cause heavy menstrual bleeding, pelvic pressure, and pain. Similar to endometriosis, fibroids can be influenced by estrogen. By decreasing estrogen levels, Elagolix may help to shrink the fibroids and improve symptoms associated with these growths.
5kg/bag/drum or 10kg/bag/drum or according to customer’s requirements.
